Caresyntax Corp., which offers an AI-powered, vendor-neutral platform integrating data from pre-planning to post-op surgery, secured $180m in a series C extension and debt financing round.
Surgical.ai participated in the funding round with a combined undisclosed eight-figure investment. Other investors included Symbiotic Capital, MTIP AG, Symbiotic...
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?